Home › Cardiomyopathy › Michigan
Cardiomyopathy clinical trials in Michigan
7 studies for Cardiomyopathy are looking for participants at sites in Michigan.
Cities in Michigan
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Clinical Trial Site, Detroit
RecruitingPhase 3
Ages 18 to 85 · All sexes · Updated Sep 16, 2026 · NCT07052903Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Henry Ford Health System, Detroit
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Aug 4, 2026 · NCT06563895Danon Disease Natural History Study
- University of Michigan, Ann Arbor
RecruitingObservational study
Ages 8 and older · All sexes · Updated Jul 28, 2026 · NCT06214507The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients
- Henry Ford Health, Detroit
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Jul 14, 2026 · NCT05034432MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
- University of Michigan, Ann Arbor
RecruitingPhase 3
Ages 18 to 90 · All sexes · Updated Mar 27, 2026 · NCT06128629Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator
- Henry Ford Health System, Detroit
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Sep 18, 2025 · NCT06964464A Study to Assess Real-world Patient Characteristics and Clinical Course for Symptomatic Patients With PKP2-ACM
- University of Michigan, Ann Arbor
- Henry Ford Hospital, Detroit
RecruitingObservational study
Ages 18 to 65 · All sexes · Updated May 16, 2025 · NCT06976606From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.